Vedolizumab for induction and maintenance of remission in ulcerative colitis
Clicks: 468
ID: 115472
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
66.0
/100
468 views
317 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #5 of 97 articles by views in The Cochrane database of systematic reviews
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Moderate to high quality data from four studies shows that vedolizumab is superior to placebo for induction of clinical remission and response and endoscopic remission in patients with moderate to severely active ulcerative colitis and prevention of relapse in patients with quiescent ulcerative coli …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (44 words).
Try re-searching for a better abstract.
| Reference Key |
sj2014thevedolizumab
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Bickston SJ;Behm BW;Tsoulis DJ;Cheng J;MacDonald JK;Khanna R;Feagan BG;; |
| Journal | The Cochrane database of systematic reviews |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
systematic review
meta-analysis
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
humans
pubmed abstract
nih
national institutes of health
national library of medicine
randomized controlled trials as topic
Antibodies
Monoclonal
Brian G Feagan
Humanized / therapeutic use*
Colitis
secondary prevention
pmid:25105240
doi:10.1002/14651858.cd007571.pub2
stephen j bickston
brian w behm
humanized / adverse effects
ulcerative / prevention & control
ulcerative / therapy*
induction chemotherapy / methods*
maintenance chemotherapy / methods*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.